Dr. Linda T. Vahdat MD
Oncologist | Medical Oncology
425 E 61st St Fl 8 New York NY, 10021About
Dr. Linda Vahdat is an oncologist practicing in New York, NY. Dr. Vahdat specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Vahdat manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Mt Sinai Sch of Med of The City Univ of Ny, New York Ny 1987
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.
- Phase I/II study of tandem cycles of high-dose chemotherapy followed by autologous hematopoietic stem cell support in women with advanced ovarian cancer.
- Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
- Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.
- Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer.
- Clinical studies with epothilones for the treatment of metastatic breast cancer.
- Epothilones: clinical update and future directions.
- Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome: etiology and emerging therapies.
- Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205.
- Eribulin mesylate for the treatment of breast cancer.
- Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes.
- Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy.
- Treatment of metastatic breast cancer: second line and beyond.
- Eribulin monotherapy versus treatment of physician's choice in patients with
- Novel treatment options in the management of metastatic breast cancer.
Clinical Trials
Dr. Linda T. Vahdat MD's Practice location
Dr. Linda T. Vahdat MD's reviews
Write ReviewPatient Experience with Dr. Vahdat
Recommended Articles
- How Is Ovarian Cancer Diagnosed?
Ovarian cancer can affect every woman in the world, including those who are at an age above 60, but also those who are younger than that. The symptoms of ovarian cancer are mild in the early stages, so many women confuse them with a regular period or ovulation pain. That is the reason why ovarian...
- A True Calling: Two-Time Cancer Survivor Sets Her Sights on Nursing
Although she has only been a nurse for a short time, Michelle McGovern’s life experience with cancer have given her a unique backbone for bedside care. There were only two things Michelle McGovern needed to do—just two little things.The first was she write a book to let her son and daughter...
- Post-traumatic Stress Disorder and Breast Cancer
When thinking about breast cancer it is important that we remember that this diagnosis will impact all aspects of a patient and their family’s life. Post-Traumatic Stress disorder (PTSD) has been shown to not only be present in people with a breast cancer diagnosis, but also to possibly play a...
- Chemotherapy Drugs for Breast Cancer
What is Chemotherapy?Also called chemo, this is a treatment with cancer killing drugs, which can be given by mouth or intravenously wherein it is injected into the veins. The medication then travels through the bloodstream to reach the cancer cells, which are based on most parts of the body. Not all...
- The Link Between Breast Implants and Lymphoma
Throughout the years, implants have risen in popularity. On an annual basis, about 400,000 women in the United States get breast implants – around 300,000 for cosmetic enlargement and around 100,000 for breast reconstruction after cancer. In the year 2015, it was estimated that 1.4 million women...
- Rate of Mastectomies Rose After Angelina Jolie Publicized Her Decision
In 2013, Angelina Jolie announced her decision to have preventative double mastectomies. At that time, she had discovered that she was a carrier of the BRCA1 gene mutation, which increased her risk of both breast and ovarian cancer.In just 2 short years following her mastectomies, she also had her...
Nearby Providers
- Dr. Donna McNamara MD92 2nd Street Hackensack NJ 07601
- Howard W. Bruckner2330 Eastchester Rd Bronx New York 10469
- Dr. William H. Nealon M.D.450 Lakeville Road New Hyde Park NY 11042
- Dr. Trevor Joseph Layne MD354 MAIN ST WEST ORANGE NJ 07052
- Rachel Beth Wellner1185 Park Ave New York NY 10128
- Orestes Sanchez703 Main St Paterson New Jersey 07503